Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Next Generation Personalized Neuroblastoma Therapy [Phase 1]
A Phase 1 trial of next-generation personalized neuroblastoma therapy has been terminated.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy [Phase 1]
Clinical trial update for the Phase 1 PEACH trial (precision medicine and adoptive cellular therapy) for neuroblastoma and diffuse intrinsic…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study evaluating a combination of liposomal irinotecan, vincristine, temozolomide, and anlotin…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma [Phase 2]
A Phase 2 study evaluating the combination of tipifarnib and naxitamab for relapsed/refractory neuroblastoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation [EARLY_Phase 1]
This is a pediatric early-phase 1 trial update evaluating intrathecal topotecan with maintenance chemotherapy for high-risk embryonal centra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) [Phase 3]
This clinical trial update describes a Phase 3 study evaluating adding 131I-MIBG or lorlatinib to intensive therapy for high-risk neuroblast…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Study of Avutometinib for People With Solid Tumor Cancers [Phase 1]
A Phase 1 study of Avutometinib for people with solid tumors, including CNS tumors and NF1-associated tumors, is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for tegavivint in recurrent or refractory solid tumors, including lymphomas and desmoid tumors, currently …
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: An Intermediate Expanded Use Trial of DFMO
This is an update on an intermediate expanded-use trial of DFMO for neuroblastoma and several embryonal CNS tumors, including medulloblastom…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Pediatric Precision Laboratory Advanced Neuroblastoma Therapy [Phase 2]
This document reports an ongoing Phase 2 clinical trial evaluating a pediatric precision laboratory therapy for neuroblastoma that is curren…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow [Phase 2]
Phase 2 clinical trial updating Naxitamab for high-risk neuroblastoma patients with primary refractory disease or incomplete response to sal…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma [Phase 2]
A Phase II clinical trial update describes evaluating the addition of N-803 to a chemoimmunotherapy backbone for relapsed or refractory neur…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma [Phase 1]
A Phase 1 trial of CUDC-907 (fimepinostat) in children and young adults with relapsed or refractory solid tumors, CNS tumors, or lymphoma ha…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma [Phase 2]
This update covers a Phase 2 clinical trial testing reduced chemotherapy combined with monoclonal antibody–based therapy in children with ne…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma [NA]
An ongoing clinical trial update for the Resource Intervention to Support Equity (RISE) study in high-risk neuroblastoma, currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma [Phase 1, Phase 2]
A clinical trial is evaluating the imaging agent Anti-GD2-800CW in patients with neuroblastoma. The study is in Phase 1/2 and currently recr…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Engineering Immune Organoids to Study Pediatric Cancer [NA]
A clinical trial update describes a study using engineered immune organoids to investigate pediatric cancers, including brain tumors, kidney…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: SPEARHEAD-3 Pediatric Study [Phase 1, Phase 2]
SPEARHEAD-3 is a pediatric study enrolling in Phase 1 and Phase 2 across multiple cancers, including synovial sarcoma, malignant peripheral …
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: 18F-DOPA II - PET Imaging Optimization [Phase 3]
Phase 3 trial of the imaging agent 18F-DOPA II for PET imaging optimization is currently recruiting, sponsored by the University of Alberta,…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas [Phase 1]
Phase 1 study evaluating CD45RA+ depleted haploidentical stem cell transplantation in children with relapsed or refractory solid tumors and …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma [Phase 1]
Phase 1 trial evaluating NKG2D.Zeta-NK cell conditioning combined with C7R.GD2.CAR-T cells in patients with relapsed or refractory neuroblas…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study. [Phase 1, Phase 2]
Multi-center, single-arm Phase I/II clinical trial assessing safety and preliminary efficacy of apatinib mesylate in combination with an iri…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma [Phase 2]
Phase 2 clinical trial evaluating the combination of Eflornithine (DFMO) and Etoposide for relapsed/refractory Neuroblastoma; currently recr…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma [Phase 2]
A Phase 2 trial update indicates naxitamab is being added to induction therapy for newly diagnosed high-risk neuroblastoma, with patient rec…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma [Phase 3]
A Phase 3 clinical trial in pediatric patients with refractory or relapsed high-risk neuroblastoma and ganglioneuroblastoma is evaluating ch…